Bi Jingquan, former head of the now-defunct China Food and Drug Administration (CFDA), is being investigated for suspected corruption, China's anti-graft watchdog said on Thursday.

Bi, 69, served as the chief of the China Food and Drug Administration from 2015 to 2018, when he introduced regulatory overhauls that spurred innovation in China’s pharmaceutical sector.

Gynecologic cancer (Gyn-Ca) treatment has seen meaningful advancements in therapeutic outcomes in the past decade with the introduction of new therapies. 1-4 Despite this progress, not all populations ...

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of new drugs and medical devices.

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for vulnerable populations.

June 4 (UPI) --Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side ...

A recent cookie recall has escalated, with the U.S. Food and Drug Administration (FDA) now designating it as a Class I recall, which is the highest risk level.

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews.

However, it is not approved by the U.S. Food and Drug Administration, and it does generally carry a warning label noting its cancer risks.

Massachusetts would have to find between $185 million and $704 million dollars a year to maintain food stamps for 1.1 million residents if the U.S. Senate approves cuts proposed in a House bill ...

But this medication has not been formally approved by the Food and Drug Administration — and research has raised concerns about its potential cancer risk, Bloomberg reported. 3.